NovaBridge Biosciences (NBP)
NASDAQ: NBP · Real-Time Price · USD
2.250
-0.130 (-5.46%)
At close: May 6, 2026, 4:00 PM EDT
2.290
+0.040 (1.78%)
After-hours: May 6, 2026, 7:55 PM EDT
NovaBridge Biosciences Market Cap
NovaBridge Biosciences has a market cap or net worth of $260.21 million as of May 6, 2026. Its market cap has increased by 273.42% in one year.
Market Cap
260.21M
Enterprise Value
52.43M
1-Year Change
273.42%
Ranking
Category
Stock Price
$2.25
Market Cap Chart
Since January 17, 2020, NovaBridge Biosciences's market cap has increased from $138.05M to $260.21M, an increase of 88.49%. That is a compound annual growth rate of 10.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 275.24M | -40.02% |
| Dec 31, 2025 | 458.86M | 562.90% |
| Dec 31, 2024 | 69.22M | -56.10% |
| Dec 29, 2023 | 157.68M | -54.60% |
| Dec 30, 2022 | 347.35M | -90.48% |
| Dec 31, 2021 | 3.65B | 9.73% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zentalis Pharmaceuticals | 290.11M |
| Protara Therapeutics | 287.73M |
| C4 Therapeutics | 284.93M |
| Editas Medicine | 283.83M |
| Cellectis | 283.24M |
| Eledon Pharmaceuticals | 280.32M |
| Foghorn Therapeutics | 279.41M |
| LENZ Therapeutics | 278.43M |